Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?

por Kotulová, Jana, Hajdúch, Marián, Džubák, Petr
Publicado 2021

2-Cl-IB-MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines

por Kotulova, Jana, Lonova, Katerina, Kubickova, Agata, Vrbkova, Jana, Kourilova, Pavla, Hajduch, Marian, Dzubak, Petr
Publicado 2022